Investing.com -- Wall Street analysts initiated coverage on Medline Industries, pointing to high visibility on revenue growth, a differentiated private-label model and scope for margin expansion after ...

Jan 12 (Reuters) - Brokerages began coverage of ‌Medline with largely bullish ratings on ‌Monday, betting on supply chain strength and brand penetration, following the firm's upsized U.S. initial ...

Medline has struck a series of new and expanded partnerships with health systems in recent months, reinforcing its position as a major supply chain player in both medical-surgical and laboratory ...

The banner across Medline's homepage today reads, "We're public." It's a bit of an understatement. The Northfield-based global medical supplies company on Dec. 16 offered about 216 million shares at ...

Medline Inc. (NASDAQ:MDLN) is one of the stocks Jim Cramer shed light on. Cramer discussed the company’s IPO during the episode, as he remarked: “So is Medline worth buying after today’s IPO and the ...

Medline is now on Nasdaq. Medline raised $6.26 billion in the largest US IPO since 2021. Overwhelming demand led to an upsized offering of 216 million shares. Medline offers 190,000 products, 43,000 ...

Medline CEO Jim Boyle (R) celebrates after ringing the opening bell at Nasdaq Marketsite headquarters on Dec. 17, 2025. Photo by Michael M. Santiago/Getty Images A blockbuster IPO from an ...

Medline Inc. completed a record-setting $6.26B IPO, allocating proceeds primarily to reduce leveraged buyout debt from 2021. MDLN operates globally with $20.6B YTD revenue, stable 10% growth, and ...

Medline Inc. (NASDAQ: MDLN) shares are trending on Thursday. Check out the current price of MDLN stock here. Shares of the healthcare company surged 41.38% in regular trading hours on Wednesday, ...

When the Mills family sold Medline Inc. to private equity in one of the largest leveraged buyouts ever, the $32 billion deal seemed the apotheosis of a Covid economy defined by low interest rates and ...

Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer reviewed Medline, a medical supplies giant that made its market debut Wednesday. He said he'd wait for a pullback to buy the stock after shares ...

Medline shares close 41% above offer price in debut Tariffs pose a challenge for Medline SpaceX, others eye 2026 listing Dec 17 (Reuters) - Medical supply giant Medline's shares rose 41% above their ...